Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus metoclopramide for prevention of intrathecal opioid-induced pruritus
PACTR202501607893334Completed
- Sponsor
- Douaa Ibrahim
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of gabapentin and metoclopramide in pruritus (3 arms), sponsored by Douaa Ibrahim. Primary endpoint: Incidence and severity of pruritus. Started Oct 2023; status: completed.
02
Drugs
gabapentinmetoclopramide
03
Conditions
pruritus
Beyond the preview
Go deeper on PACTR202501607893334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501607893334.